Analyst Price Target is $138.07
▼ -11.66% Downside Potential
This price target is based on 8 analysts offering 12 month price targets for Omnicell in the last 3 months. The average price target is $138.07, with a high forecast of $188.00 and a low forecast of $84.00. The average price target represents a -11.66% upside from the last price of $156.29.
Current Consensus is
The current consensus among 8 contributing investment analysts is to buy stock in Omnicell. This rating has held steady since January 2020, when it changed from a Hold consensus rating.
Omnicell, Inc. engages in the provision of medication management automation solutions and adherence tools for healthcare systems and pharmacies. Its solutions include intelligence, platform and interoperability, central pharmacy dispensing, medication adherence, population health and point of care automation. The company was founded by Randall A. Lipps in September 1992 and is headquartered in Mountain View, CA.